{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:26:43Z","timestamp":1790832403557,"version":"4.1.0"},"reference-count":122,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.cyto.2022.155826","type":"journal-article","created":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T22:49:38Z","timestamp":1644446978000},"page":"155826","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["SARS-CoV-2 infection causes intestinal cell damage: Role of interferon\u2019s imbalance"],"prefix":"10.1016","volume":"152","author":[{"given":"Stefany","family":"Guimar\u00e3es Sousa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f4nio","family":"Kleiton de Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Maria Carvalho Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Sofia Miranda Loiola Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diva","family":"de Aguiar Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarcisio","family":"Vieira de Brito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 Luiz dos Reis","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2022.155826_b0005","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1126\/science.abd2208","article-title":"Interferon responses in viral pneumonias","volume":"369","author":"Grajales-Reyes","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.cyto.2022.155826_b0010","unstructured":"World Health Organization (WHO), Coronavirus disease (COVID-19) pandemic: Numbers at a glance (2020). https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019 (accessed 15 October 2021)."},{"key":"10.1016\/j.cyto.2022.155826_b0015","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S2468-1253(20)30083-2","article-title":"Prolonged presence of SARS-CoV-2 viral RNA in faecal samples","volume":"5","author":"Wu","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.cyto.2022.155826_b0020","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1053\/j.gastro.2020.02.055","article-title":"Evidence for gastrointestinal infection of SARS-CoV-2","volume":"158","author":"Xiao","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2022.155826_b0025","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jmii.2020.03.021","article-title":"Prolonged viral shedding in feces of pediatric patients with coronavirus disease 2019","volume":"53","author":"Xing","year":"2020","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.cyto.2022.155826_b0030","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/s41591-020-0817-4","article-title":"Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding","volume":"26","author":"Xu","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.cyto.2022.155826_b0035","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cytogfr.2020.05.002","article-title":"COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons","volume":"53","author":"Nile","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"issue":"1","key":"10.1016\/j.cyto.2022.155826_b0040","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-17665-9","article-title":"Activation and evasion of type I interferon responses by SARS-CoV-2","volume":"11","author":"Lei","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cyto.2022.155826_b0045","doi-asserted-by":"crossref","first-page":"13958","DOI":"10.1074\/jbc.AC120.013788","article-title":"Inhibition of SARS\u2013CoV-2 by type I and type III interferons","volume":"295","author":"Felgenhauer","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cyto.2022.155826_b0050","article-title":"Critical role of type III interferon in controlling SARS-CoV-2 infection, replication and spread in primary human intestinal epithelial cells","author":"Stanifer","year":"2020","journal-title":"BioRxiv"},{"key":"10.1016\/j.cyto.2022.155826_b0055","first-page":"37","article-title":"Pharmacology of the internal anal sphincter","author":"Burleigh","year":"2000","journal-title":"Coloproctology and the Pelvic Floor"},{"key":"10.1016\/j.cyto.2022.155826_b0060","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/S0024-3205(97)00809-6","article-title":"A morphological study of the enteric mucosal epithelium in the streptozotocin-diabetic mouse","volume":"61","author":"Ettarh","year":"2000","journal-title":"Life Sci."},{"key":"10.1016\/j.cyto.2022.155826_b0065","series-title":"Histologia b\u00e1sica","author":"Junqueira","year":"2008"},{"key":"10.1016\/j.cyto.2022.155826_b0070","series-title":"Netter, Bases da histologia","author":"Ovalle","year":"2008"},{"key":"10.1016\/j.cyto.2022.155826_b0075","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/BF01556110","article-title":"Regulation of gastrointestinal mucosal growth","volume":"3","author":"Johnson","year":"1979","journal-title":"World J. Surg."},{"key":"10.1016\/j.cyto.2022.155826_b0080","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.4049\/jimmunol.1200955","article-title":"Th17 cells upregulate polymeric Ig receptor and intestinal IgA and contribute to intestinal homeostasis","volume":"189","author":"Cao","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2022.155826_b0085","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/mi.2014.134","article-title":"Interleukin (IL)-21 promotes intestinal IgA response to microbiota","volume":"8","author":"Cao","year":"2015","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.cyto.2022.155826_b0090","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/mi.2015.49","article-title":"Regulatory immune cells in regulation of intestinal inflammatory response to microbiota","volume":"8","author":"Sun","year":"2015","journal-title":"Mucosal Immunol."},{"issue":"7","key":"10.1016\/j.cyto.2022.155826_b0095","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a018341","article-title":"Regulatory T Cells and Immune Tolerance in the Intestine","volume":"5","author":"Harrison","year":"2013","journal-title":"Cold Spring Harb Perspect Biol."},{"issue":"7","key":"10.1016\/j.cyto.2022.155826_b0100","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat Rev Immunol."},{"key":"10.1016\/j.cyto.2022.155826_b0105","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.4049\/jimmunol.177.7.4376","article-title":"Blockade of CTLA-4 on CD4+CD25+ regulatory T cells abrogates their function in vivo","volume":"177","author":"Read","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2022.155826_b0110","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0016-5085(98)70381-6","article-title":"Inflammatory bowel disease: etiology and pathogenesis","volume":"115","author":"Fiochi","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2022.155826_b0115","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0891-5849(02)00853-5","article-title":"Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease","volume":"33","author":"Pavlick","year":"2002","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cyto.2022.155826_b0120","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1590\/S0101-98802008000100018","article-title":"Biologia molecular das doen\u00e7as inflamat\u00f3rias intestinais","volume":"28","author":"Pinho","year":"2008","journal-title":"Rev. Bras. Coloproctol."},{"issue":"1","key":"10.1016\/j.cyto.2022.155826_b0125","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev-virology-110615-042301","article-title":"Structure, function, and evolution of coronavirus spike proteins","volume":"3","author":"Li","year":"2016","journal-title":"Annu. Rev. Virol."},{"key":"10.1016\/j.cyto.2022.155826_b0130","doi-asserted-by":"crossref","first-page":"eabd4758","DOI":"10.1126\/sciimmunol.abd4758","article-title":"Finding Ccmel-ot: A holy grail against pandemic SARS-CoV-2?","volume":"49","author":"Soong","year":"2020","journal-title":"Science Immunol."},{"key":"10.1016\/j.cyto.2022.155826_b0135","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1006\/viro.2000.0757","article-title":"Coronavirus spike proteins in viral entry and pathogenesis","volume":"279","author":"Gallagher","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.cyto.2022.155826_b0140","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.cyto.2022.155826_b0145","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1136\/gutjnl-2020-320953","article-title":"Digestive system is a potential route of COVID-19: an analysis of single-cell coexpression pattern of key proteins in viral entry process","volume":"69","author":"Zhang","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.cyto.2022.155826_b0150","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/cr.2016.152","article-title":"Cryo-Electron microscopy structures of the SARS-CoV spike glycoprotein reveal a prerequisite conformational state for receptor binding","volume":"27","author":"Gui","year":"2017","journal-title":"Cell Res."},{"key":"10.1016\/j.cyto.2022.155826_b0155","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"JA Goldsmith1, CL Hsieh, O Abiona, BS Graham, JS McLellan, Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.cyto.2022.155826_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2021.104892","article-title":"The differences in SARS-CoV and SARS-CoV-2 specific co-expression network mediated biological process in human gut enterocytes","volume":"92","author":"Nayak","year":"2021","journal-title":"Infect Genet Evol."},{"issue":"2020","key":"10.1016\/j.cyto.2022.155826_b0165","first-page":"507","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2019","journal-title":"Lancet"},{"issue":"2020","key":"10.1016\/j.cyto.2022.155826_b0170","first-page":"1061","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan","volume":"323","author":"Wang","year":"2019","journal-title":"China. JAMA"},{"issue":"5","key":"10.1016\/j.cyto.2022.155826_b0175","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/jgh.15047","article-title":"Review Covid-19 and the digestive system","volume":"35","author":"Wong","year":"2020","journal-title":"J Gastroenterol Hepatol."},{"key":"10.1016\/j.cyto.2022.155826_b0180","article-title":"Gastrointestinal Manifestations of COVID-19","volume":"1\u20135","author":"Ouali","year":"2020","journal-title":"Cleve. Clin. J. Med."},{"issue":"13","key":"10.1016\/j.cyto.2022.155826_b0185","first-page":"7506","article-title":"Gastrointestinal Symptoms and Digestive Comorbidities in an Italian Cohort of Patients With COVID-19","volume":"24","author":"Papa","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.cyto.2022.155826_b0190","doi-asserted-by":"crossref","DOI":"10.31744\/einstein_journal\/2020RW5909","article-title":"COVID-19 and the Gastrointestinal Tract: What do We Already Know?","volume":"18","author":"Almeida","year":"2020","journal-title":"Einstein."},{"issue":"1","key":"10.1016\/j.cyto.2022.155826_b0195","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1080\/22221751.2020.1729071","article-title":"Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes","volume":"9","author":"Zhang","year":"2020","journal-title":"Emerg. Microbes. Infect."},{"issue":"2020","key":"10.1016\/j.cyto.2022.155826_b0200","first-page":"929","article-title":"First case of 2019 novel coronavirus in the United States","volume":"382","author":"Holshue","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"10.1016\/j.cyto.2022.155826_b0205","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1001\/jama.2020.3204","article-title":"Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore","volume":"21323","author":"Young","year":"2020","journal-title":"JAMA."},{"issue":"9","key":"10.1016\/j.cyto.2022.155826_b0210","article-title":"COVID-19: Focus on the Lungs But do Not Forget the Gastrointestinal","volume":"50","author":"Smyk","year":"2020","journal-title":"Tract. Eur. J. Clin. Invest."},{"key":"10.1016\/j.cyto.2022.155826_b0215","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1099\/vir.0.064717-0","article-title":"Role of sialic acids in feline enteric coronavirus infections","volume":"95","author":"Desmarets","year":"2014","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.cyto.2022.155826_b0220","doi-asserted-by":"crossref","unstructured":"MM Lamers, J Beumer, J Vaart, K Knoops, J Puschhof, TI Breugem, RBG Ravelli, JP Schayck, AZ Mykytyn, HQ Duimel, E Donselaar, S Riesebosch, HJH Kuijpers, D Schipper, WJ Wetering, M Graaf, M Koopmans, E Cuppen, PJ Peters, BL Haagmans, H Clevers. SARS-CoV-2 productively infects human gut enterocytes. Science. 3, 369, 6499 (2020) 50-54.","DOI":"10.1126\/science.abc1669"},{"issue":"6","key":"10.1016\/j.cyto.2022.155826_b0225","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13355","article-title":"Hyponatremia: A possible immuno-neuroendocrine interface with COVID-19 in a kidney transplant recipient","volume":"22","author":"Tantisattamo","year":"2020","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.cyto.2022.155826_b0230","first-page":"514","article-title":"Immunity and immunopathology to viruses: what decides the outcome?","volume":"10","author":"Rouse","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2022.155826_b0235","doi-asserted-by":"crossref","unstructured":"FY Chang, HC Chen, PJ Chen, MS Ho, SL Hsieh, JC Lin, FT Liu, HK Sytwu, Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19). J. Biomed. Sci. 27 (2020) 1-13.","DOI":"10.1186\/s12929-020-00663-w"},{"key":"10.1016\/j.cyto.2022.155826_b0240","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.imlet.2016.07.003","article-title":"Mast cells as effector cells of innate immunity and regulators of adaptive immunity","volume":"178","author":"Cardamone","year":"2016","journal-title":"Immunol Lett."},{"key":"10.1016\/j.cyto.2022.155826_b0245","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.3390\/ijms20174241","article-title":"Mast Cell Responses to Viruses and Pathogen Products","volume":"20","author":"Marshall","year":"2019","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.cyto.2022.155826_b0250","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s12026-012-8377-4","article-title":"CD St Laurent, TC Moon, NSA Dean Befus, Limited replication of influenza A virus in human mast cells","volume":"56","author":"Marcet","year":"2013","journal-title":"Immunol. Res."},{"key":"10.1016\/j.cyto.2022.155826_b0255","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jprot.2017.06.018","article-title":"Proteomics to study macrophage response to viral infection","volume":"180","author":"Nyman","year":"2018","journal-title":"J Proteomics."},{"issue":"2","key":"10.1016\/j.cyto.2022.155826_b0260","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jaci.2009.12.980","article-title":"Overview of the Immune Response","volume":"125","author":"Chaplin","year":"2010","journal-title":"J Allergy Clin Immunol."},{"key":"10.1016\/j.cyto.2022.155826_b0265","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1189\/jlb.4VMR1114-555R","article-title":"Neutrophils in viral infections: Current concepts and caveats","volume":"98","author":"Galani","year":"2015","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cyto.2022.155826_b0270","unstructured":"K Laing, Immune Responses to Viruses. British Society for Immunology."},{"key":"10.1016\/j.cyto.2022.155826_b0275","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.3389\/fimmu.2019.01306","article-title":"Role of Dendritic Cells in Natural Immune Control of HIV-1 Infection","volume":"10","author":"Martin-Gayo","year":"2019","journal-title":"Front Immunol."},{"key":"10.1016\/j.cyto.2022.155826_b0280","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1590\/S0365-05962004000600002","article-title":"Immune response mechanisms to infections","volume":"79","author":"Machado","year":"2004","journal-title":"An bras Dermatol."},{"key":"10.1016\/j.cyto.2022.155826_b0285","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.immuni.2006.08.007","article-title":"Type I interferons in host defense","volume":"25","author":"Stetson","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2022.155826_b0290","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ni875","article-title":"IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex","volume":"4","author":"Kotenko","year":"2003","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.cyto.2022.155826_b0295","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1128\/CMR.14.4.778-809.2001","article-title":"Antiviral actions of interferons","volume":"14","author":"Samuel","year":"2001","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.cyto.2022.155826_b0300","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.cyto.2008.07.009","article-title":"Innate immune response to viral infection","volume":"43","author":"Koyama","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2022.155826_b0305","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.chom.2020.05.009","article-title":"The Innate Immune System: Fighting on the Front Lines or Fanning the Flames of COVID-19?","volume":"27","author":"McKechnie","year":"2020","journal-title":"Cell Host & Microbe."},{"key":"10.1016\/j.cyto.2022.155826_b0310","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.mib.2010.05.009","article-title":"Viral tricks to grid-lock the type Iinterferon system","volume":"13","author":"Versteeg","year":"2010","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.cyto.2022.155826_b0315","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.640073","article-title":"New Insights Into the Physiopathology of COVID-19: SARS-CoV-2-Associated Gastrointestinal Illness","volume":"8","author":"Devaux","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.cyto.2022.155826_b0320","doi-asserted-by":"crossref","first-page":"101300","DOI":"10.1016\/j.smim.2019.101300","article-title":"Global virus outbreaks: Interferons as 1st responders","volume":"43","author":"Wang","year":"2019","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.cyto.2022.155826_b0325","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000495172","article-title":"Type III interferons in viral infection and antiviral immunity","volume":"51","author":"Zhou","year":"2018","journal-title":"Cell Physiol. Biochem."},{"key":"10.1016\/j.cyto.2022.155826_b0330","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.3389\/fimmu.2017.01758","article-title":"Interplay between Janus Kinase\/Signal Transducer and Activator of Transcription Signaling Activated by Type I Interferons and Viral Antagonism","volume":"8","author":"Nan","year":"2017","journal-title":"Front Immunol."},{"key":"10.1016\/j.cyto.2022.155826_b0335","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev-immunol-032713-120231","article-title":"Interferon-stimulated genes: a complex webof host defenses","volume":"32","author":"Schneider","year":"2014","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2022.155826_b0340","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3390\/v10010046","article-title":"Distinct effects of type I and III interferons on enteric viruses","volume":"10","author":"Ingle","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.cyto.2022.155826_b0345","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cytogfr.2016.02.010","article-title":"The unique role of STAT2 in constitutive and IFN-induced transcription and antiviral responses","volume":"29","author":"Blaszczyk","year":"2016","journal-title":"Cytokine Growth Factor Rer."},{"key":"10.1016\/j.cyto.2022.155826_b0350","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/ni.2229","article-title":"Intrinsic antiviral immunity","volume":"13","author":"Yan","year":"2012","journal-title":"Nature immunol."},{"key":"10.1016\/j.cyto.2022.155826_b0355","doi-asserted-by":"crossref","unstructured":"K Al Moussawi, E Ghigo, U Kalinke, L Alexopoulou, JL Mege, B Desnues, Type I interferon induction is detrimental during infection with the Whipple's disease bacterium, Tropheryma whipplei. PLoS pathogens 6 (2010) e1000722.","DOI":"10.1371\/journal.ppat.1000722"},{"key":"10.1016\/j.cyto.2022.155826_b0360","first-page":"2094","article-title":"Early type I interferon-mediated signals on B cells pecifically enhance antiviral humoral responses","volume":"36","author":"Fink","year":"2006","journal-title":"EJI."},{"key":"10.1016\/j.cyto.2022.155826_b0365","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.4049\/jimmunol.176.6.3315","article-title":"Cutting Edge: The direct action of type I IFN on CD4 T cells is critical for sustaining clonal expansion in response to a viral but not a bacterial infection","volume":"176","author":"Havenar-Daughton","year":"2006","journal-title":"J. Immun."},{"key":"10.1016\/j.cyto.2022.155826_b0370","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1084\/jem.20050821","article-title":"Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection","volume":"202","author":"Kolumam","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2022.155826_b0375","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nri3787","article-title":"Type I interferons in infectious disease","volume":"15","author":"McNab","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cyto.2022.155826_b0380","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cyto.2022.155826_b0385","doi-asserted-by":"crossref","first-page":"465","DOI":"10.4049\/jimmunol.1801376","article-title":"Viral resistance and IFN signaling in STAT2","volume":"203","author":"Dehler","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2022.155826_b0390","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature09907","article-title":"A diverse range of gene products are effectors of the type I interferon antiviral response","volume":"472","author":"Schoggins","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2022.155826_b0395","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/hep.26959","article-title":"Type I and type III interferon-induced imune response: it\u2019s a matter of kinetics and magnitude","volume":"59","author":"Olagnier","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2022.155826_b0400","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/hep.21312","article-title":"Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes","volume":"44","author":"Doyle","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2022.155826_b0405","doi-asserted-by":"crossref","first-page":"7749","DOI":"10.1128\/JVI.02438-06","article-title":"Type III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinases","volume":"81","author":"Zhou","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.cyto.2022.155826_b0410","doi-asserted-by":"crossref","unstructured":"K Pervolaraki, TS Rastgou, D Albrecht, F Bormann, C Bamford, JL Mendoza, KC Garcia, J McLauchlan, T H\u00f6fer, ML Stanifer, S Boulant, Differential induction of interferon stimulated genes between type I and type III interferons is independent of interferon receptor abundance. PLoS Pathog 14 (2018) e1007420.","DOI":"10.1371\/journal.ppat.1007420"},{"key":"10.1016\/j.cyto.2022.155826_b0415","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/hep.26653","article-title":"Kinetic differences in the induction of interferon stimulated genes by interferon-\u03b1 and interleukin 28B are altered by infection with hepatitis C virus","volume":"59","author":"Jilg","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2022.155826_b0420","doi-asserted-by":"crossref","unstructured":"C Sommereyns, S Paul, P Staeheli, T Michiels, IFN-lambda (IFN-\u03bb) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog 4 (2008) e1000017.","DOI":"10.1371\/journal.ppat.1000017"},{"key":"10.1016\/j.cyto.2022.155826_b0425","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00459","article-title":"Type I and Type III Interferons display different dependency on mitogen-activated protein kinases to mount an antiviral state in the human gut","volume":"8","author":"Pervolaraki","year":"2017","journal-title":"Front Immunol."},{"key":"10.1016\/j.cyto.2022.155826_b0430","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01302","article-title":"Identification of a predominantly interferon-\u03bb-induced transcriptional profile in murine intestinal epithelial cells","volume":"8","author":"Selvakumar","year":"2017","journal-title":"Front Immunol."},{"issue":"7","key":"10.1016\/j.cyto.2022.155826_b0435","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02079-16","article-title":"Expression of Ifnlr1 on intestinal epithelial cells is critical to the antiviral effects of interferon lambda against norovirus and reovirus","volume":"91","author":"Baldridge","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.cyto.2022.155826_b0440","doi-asserted-by":"crossref","first-page":"5670","DOI":"10.1128\/JVI.00272-10","article-title":"Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections","volume":"84","author":"Mordstein","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.cyto.2022.155826_b0445","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1038\/s41564-019-0470-1","article-title":"IFN-I and IL-22 mediate protective effects of intestinal viral infection","volume":"4","author":"Neil","year":"2019","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.cyto.2022.155826_b0450","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1172\/JCI60945","article-title":"Plasmacytoid dendritic cells promote rotavirus-induced human and murine B cell responses","volume":"123","author":"Deal","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.cyto.2022.155826_b0455","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms8090","article-title":"C Reis e Sousa, P Staeheli, BA Blacklaws, JL Heeney, AC Hayday, Intestinal intraepithelial lymphocyte activation promotes innate antiviral resistance","volume":"6","author":"Swamy","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cyto.2022.155826_b0460","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.virusres.2016.05.015","article-title":"Immune evasion of porcine enteric coronaviruses and viral modulation of antiviral innate signaling","volume":"226","author":"Zhang","year":"2016","journal-title":"Virus Res."},{"key":"10.1016\/j.cyto.2022.155826_b0465","doi-asserted-by":"crossref","first-page":"7944","DOI":"10.1073\/pnas.1100552108","article-title":"IFN-lambda determines the intestinal epithelial antiviral host defense","volume":"108","author":"Pott","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cyto.2022.155826_b0470","doi-asserted-by":"crossref","first-page":"eabc3582","DOI":"10.1126\/sciimmunol.abc3582","article-title":"TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes","volume":"5","author":"Zang","year":"2020","journal-title":"Sci. Immunol."},{"issue":"8","key":"10.1016\/j.cyto.2022.155826_b0475","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.cgh.2020.04.001","article-title":"Diarrhea During COVID-19 Infection: pathogenesis, epidemiology, prevention, and management","volume":"18","author":"D\u2019Amico","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cyto.2022.155826_b0480","doi-asserted-by":"crossref","first-page":"10213","DOI":"10.1128\/JVI.78.19.10213-10220.2004","article-title":"Pathogenesis of Intestinal and Systemic Rotavirus Infection","volume":"78","author":"Ramig","year":"2004","journal-title":"J Virol."},{"key":"10.1016\/j.cyto.2022.155826_b0485","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1203\/00006450-200104000-00023","article-title":"Evidence for an Innate Immune Response in the Immature Human Intestine: Toll-Like Receptors on Fetal Enterocytes","volume":"49","author":"Fusunyan","year":"2001","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.cyto.2022.155826_b0490","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1053\/gast.2001.20907","article-title":"Interferon gamma induces enterocyte resistance against infection by the intracellular pathogen Cryptosporidium parvum","volume":"120","author":"Pollok","year":"2001","journal-title":"Gastroenterology."},{"issue":"1","key":"10.1016\/j.cyto.2022.155826_b0495","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0016-5085(97)70083-0","article-title":"Interferon gamma and interleukin 1, but not interferon alfa, inhibit rotavirus entry into human intestinal cell lines","volume":"113","author":"Bass","year":"1997","journal-title":"Gastroenterology."},{"issue":"6","key":"10.1016\/j.cyto.2022.155826_b0500","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.chom.2020.05.008","article-title":"Type I and Type III Interferons \u2013 Induction, Signaling, Evasion, and Application to Combat COVID-19","volume":"27","author":"Park","year":"2020","journal-title":"Cell Host & Microbe"},{"key":"10.1016\/j.cyto.2022.155826_b0505","doi-asserted-by":"crossref","first-page":"eabd1554","DOI":"10.1126\/sciimmunol.abd1554","article-title":"Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19","volume":"5","author":"Lee","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.cyto.2022.155826_b0510","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.cell.2020.04.035","article-title":"SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues","volume":"181","author":"Ziegler","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.cyto.2022.155826_b0515","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nature11228","article-title":"ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation","volume":"487","author":"Hashimoto","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2022.155826_b0520","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S2468-1253(20)30126-6","article-title":"Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis","volume":"5","author":"Mao","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"9","key":"10.1016\/j.cyto.2022.155826_b0525","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1093\/ecco-jcc\/jjaa061","article-title":"Are Patients with Inflammatory Bowel Disease at Increased Risk for Covid-19 Infection?","volume":"14","author":"Monteleone","year":"2020","journal-title":"J. Crohn's Colitis"},{"key":"10.1016\/j.cyto.2022.155826_b0530","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.immuni.2015.07.001","article-title":"Interferon-\u03bb: immune functions at barrier surfaces and beyond","volume":"43","author":"Lazear","year":"2015","journal-title":"Immunity"},{"issue":"17","key":"10.1016\/j.cyto.2022.155826_b0535","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00565-20","article-title":"Inactivating Three Interferon Antagonists Attenuates: Pathogenesis of an Enteric Coronavirus","volume":"94","author":"Deng","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.cyto.2022.155826_b0540","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1126\/science.1258025","article-title":"Commensal microbes and interferon-\u03bb determine persistence of enteric murine norovirus infection","volume":"347","author":"Baldridge","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.cyto.2022.155826_b0545","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190295","article-title":"Type III interferons: Balancing tissue tolerance and resistance to pathogen invasion","volume":"217","author":"Broggi","year":"2020","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.cyto.2022.155826_b0550","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/imr.12195","article-title":"The role of type I interferons in intestinal infection, homeostasis, and inflammation","volume":"260","author":"Cho","year":"2014","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cyto.2022.155826_b0555","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cytogfr.2008.01.001","article-title":"Interferon and cytokine responses to SARS-coronavirus infection","volume":"19","author":"Thiel","year":"2008","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.cyto.2022.155826_b0560","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.virol.2007.01.020","article-title":"Group 2 coronaviruses prevent immediate early interferon induction by protection of viral RNA from host cell recognition","volume":"361","author":"Versteeg","year":"2007","journal-title":"Virology"},{"issue":"7","key":"10.1016\/j.cyto.2022.155826_b0565","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41577-020-0346-x","article-title":"Dysregulation of type I interferon responses in COVID-19","volume":"20","author":"Acharya","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cyto.2022.155826_b0570","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2217\/fvl-2020-0404","article-title":"Association of administration of IFN-\u03b1 with mortality among patients hospitalized with coronavirus disease 2019","volume":"16","author":"Liu","year":"2021","journal-title":"Future Virol."},{"key":"10.1016\/j.cyto.2022.155826_b0575","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.coviro.2012.04.004","article-title":"SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon","volume":"2","author":"Totura","year":"2012","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.cyto.2022.155826_b0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104811","article-title":"Antiviral activities of type I interferons to SARS-CoV-2 infection","volume":"179","author":"Mantlo","year":"2020","journal-title":"Antiviral Res."},{"key":"10.1016\/j.cyto.2022.155826_b0585","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.cyto.2022.155826_b0590","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/mi.2017.118","article-title":"GPR43 mediates microbiota metabolite SCFA regulation of antimicrobial peptide expression in intestinal epithelial cells via activation of mTOR and STAT3","volume":"11","author":"Zhao","year":"2018","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.cyto.2022.155826_b0595","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.3389\/fmicb.2020.01302","article-title":"Main clinical features of COVID-19 and potential prognostic and therapeutic value of the microbiota in SARS-CoV-2 infections","volume":"11","author":"He","year":"2020","journal-title":"Front Microbiol."},{"key":"10.1016\/j.cyto.2022.155826_b0600","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/j.gastro.2020.03.065","article-title":"Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong Cohort: Systematic review and meta-analysis","volume":"159","author":"Cheung","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2022.155826_b0605","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(03)13410-1","article-title":"Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong","volume":"361","author":"Donnelly","year":"2003","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.cyto.2022.155826_b0610","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S1473-3099(13)70204-4","article-title":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study","volume":"13","author":"Assiri","year":"2013","journal-title":"Lancet Infect. Dis."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466622000357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466622000357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:42:34Z","timestamp":1760910154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466622000357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":122,"alternative-id":["S1043466622000357"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2022.155826","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SARS-CoV-2 infection causes intestinal cell damage: Role of interferon\u2019s imbalance","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2022.155826","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155826"}}